LoadingLoadingLoadingNet selling: insiders sold $5.5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Millennium
$18.7M
added
Sells/Trims (2)
Point72
$51.8M
sold
Farallon Capital
$29.9M
sold
Top-trader positions in MLYS could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 11, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.57 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 11, 2026 | -$2.85 / -$0.57Alpha Vantage | -$2.28 miss | $0.00 No estimate | Unavailable |
| Mar 31, 2026 | May 6, 2026 | -$0.47 / -$0.44Alpha Vantage | -6.82% miss | $0.00 No estimate | Unavailable |
| Dec 31, 2025 | Mar 12, 2026 | -$0.40 / -$0.94Alpha Vantage | +57.45% beat | $0.00 No estimate | Unavailable |
| Sep 30, 2025 | Nov 10, 2025 | -$0.52 / -$0.61Alpha Vantage | +14.75% beat | $0.00 No estimate | Unavailable |
| Jun 30, 2025 | Aug 12, 2025 | -$0.66 / -$0.74Alpha Vantage | +10.81% beat | $0.00 No estimate | Unavailable |
| Mar 31, 2025 | May 12, 2025 | -$0.79 / -$0.98Alpha Vantage | +19.39% beat | $0.00 No estimate | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | -$0.98 / -$1.08Alpha Vantage | +9.26% beat | $34.0K No estimate | Unavailable |
| Sep 30, 2024 | Nov 11, 2024 | -$1.13 / -$0.83Alpha Vantage | -36.14% miss | $0.00 No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | $15.0K | $13.0K | $6.0K | — |
| Gross profit | -$15.0K | -$13.0K | -$6.0K | — |
| What it spent | ||||
| Research and development | $31.4M | $24.4M | $24.4M | $221.4M |
| Sales and admin | $9.7M | $13.9M | $21.0M | $24.7M |
| Total operating expenses | $41.1M | $38.3M | $45.3M | $246.0M |
| What was left | ||||
| Operating profit | -$41.1M | -$38.3M | -$45.3M | -$246.0M |
| Profit before tax | -$36.9M | -$32.2M | -$39.3M | -$241.1M |
| Net profit | -$36.9M | -$32.2M | -$39.3M | -$241.1M |
| EBITDA | -$36.9M | -$32.2M | -$39.3M | -$241.1M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
